Translation regulatory factor RBM3 is a proto-oncogene that prevents mitotic catastrophe

Oncogene

Volumn 27, Issue 33, 2008, Pages 4544-4556

  Sureban, S M ^a   Ramalingam, S ^a   Natarajan, G ^a   May, R ^a   Subramaniam, D ^a   Bishnupuri, K S ^b   Morrison, A R ^b   Dieckgraefe, B K ^b   Brackett, D J ^a,c   Postier, R G ^a,c   Houchen, C W ^a,c   Anant, S ^a,c  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c OU Cancer Institute   (United States)

Author keywords

Cell cycle; Cyclooxygenase 2; Mitosis; RNA stability; Transformation

Indexed keywords

CASPASE; CDC25C PROTEIN; CHECKPOINT KINASE 1; CHECKPOINT KINASE 2; CYCLIN B1; CYCLOOXYGENASE 2; INTERLEUKIN 8; MESSENGER RNA; NUCLEOCYTOPLASMIC TRANSPORT PROTEIN; PROSTAGLANDIN E2; PROTEIN TYROSINE PHOSPHATASE; PROTO ONCOGENE PROTEIN RBM3; SMALL INTERFERING RNA; VASCULOTROPIN;

AGAR MEDIUM; ANCHORAGE INDEPENDENT GROWTH; ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL GROWTH; CELL PROLIFERATION; CELL STRAIN 3T3; CELL STRAIN HCT116; COLON MUCOSA; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; INTESTINE EPITHELIUM CELL; MALE; MALIGNANT TRANSFORMATION; MITOSIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTO ONCOGENE; PROTO ONCOGENE RBM3; RNA STABILITY; RNA TRANSLATION; SPHEROID CELL; TRANSLATION REGULATION; TUMOR XENOGRAFT; UPREGULATION;

ANIMALS; CELL CYCLE PROTEINS; CELL TRANSFORMATION, NEOPLASTIC; COLONIC NEOPLASMS; CYCLOOXYGENASE 2; DINOPROSTONE; FEMALE; FIBROBLASTS; HELA CELLS; HUMANS; INTERLEUKIN-8; MICE; MICE, NUDE; MITOSIS; NEOPLASM TRANSPLANTATION; NIH 3T3 CELLS; PROTEIN BIOSYNTHESIS; PROTO-ONCOGENE PROTEINS; RNA STABILITY; RNA, MESSENGER; RNA, NEOPLASM; RNA-BINDING PROTEINS; SPHEROIDS, CELLULAR; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 48649095659     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2008.97     Document Type: Article

References (56)

1. Andreis PG, Whitfield JF, Armato U. (1981). Stimulation of DNA synthesis and mitosis of hepatocytes in primary cultures of neonatal rat liver by arachidonic acid and prostaglandins. Exp Cell Res 134: 265-272.
2. Blaxall BC, Dwyer-Nield LD, Bauer AK, Bohlmeyer TJ, Malkinson AM, Port JD. (2000). Differential expression and localization of the mRNA binding proteins, AU-rich element mRNA binding protein (AUF1) and Hu antigen R (HuR), in neoplastic lung tissue. Mol Carcinog 28: 76-83.
3. Bulavin DV, Amundson SA, Fornace AJ. (2002). p38 and Chk1 kinases: different conductors for the G(2)/M checkpoint symphony. Curr Opin Genet Dev 12: 92-97.
4. Canman CE. (2001). Replication checkpoint: preventing mitotic catastrophe. Curr Biol 11: R121-R124.
5. Carpenter B, McKay M, Dundas SR, Lawrie LC, Telfer C, Murray GI. (2006). Heterogeneous nuclear ribonucleoprotein K is over expressed, aberrantly localised and is associated with poor prognosis in colorectal cancer. Br J Cancer 95: 921-927.
6. Chen CY, Shyu AB. (1995). AU-rich elements: characterization and importance in mRNA degradation. Trends Biochem Sci 20: 465-470.
7. Chen CY, Xu N, Shyu AB. (1995). mRNA decay mediated by two distinct AU-rich elements from c-fos and granulocyte-macrophage colony-stimulating factor transcripts: different deadenylation kinetics and uncoupling from translation. Mol Cell Biol 15: 5777-5788.
8. Chen YQ, Hsieh JT, Yao F, Fang B, Pong RC, Cipriano SC et al. (1999). Induction of apoptosis and G2/M cell cycle arrest by DCC. Oncogene 18: 2747-2754.
9. Cok SJ, Morrison AR. (2001). The 3′-untranslated region of murine cyclooxygenase-2 contains multiple regulatory elements that alter message stability and translational efficiency. J Biol Chem 276: 23179-23185.
10. Danno S, Nishiyama H, Higashitsuji H, Yokoi H, Xue JH, Itoh K et al. (1997). Increased transcript level of RBM3, a member of the glycine-rich RNA-binding protein family, in human cells in response to cold stress. Biochem Biophys Res Commun 236: 804-807.
11. Denkert C, Koch I, von Keyserlingk N, Noske A, Niesporek S, Dietel M et al. (2006). Expression of the ELAV-like protein HuR in human colon cancer: association with tumor stage and cyclooxygenase-2. Mod Pathol 19: 1261-1269.
12. Denkert C, Weichert W, Winzer KJ, Muller BM, Noske A, NiesporekS et al. (2004). Expression of the ELAV-like protein HuR is associated with higher tumor grade and increased cyclooxygenase-2 expression in human breast carcinoma. Clin Cancer Res 10: 5580-5586.
13. Derry JM, Kerns JA, Francke U. (1995). RBM3, a novel human gene in Xp11.23 with a putative RNA-binding domain. Hum Mol Genet 4: 2307-2311.
14. Deschenes-Furry J, Belanger G, Mwanjewe J, Lunde JA, Parks RJ, Perrone-Bizzozero N et al. (2005). The RNA-binding protein HuR binds to acetylcholinesterase transcripts and regulates their expression in differentiating skeletal muscle cells. J Biol Chem 280: 25361-25368.
15. Dixon DA, Kaplan CD, McIntyre TM, Zimmerman GA, Prescott SM. (2000). Post-transcriptional control of cyclooxygenase-2 gene expression. The role of the 3′-untranslated region. J Biol Chem 275: 11750-11757.
16. Dixon DA, Tolley ND, King PH, Nabors LB, McIntyre TM, Zimmerman GA et al. (2001). Altered expression of the mRNA stability factor HuR promotes cyclooxygenase-2 expression in colon cancer cells. J Clin Invest 108: 1657-1665.
17. Doree M, Hunt T. (2002). From Cdc2 to Cdk1: when did the cell cycle kinase join its cyclin partner? J Cell Sci 115: 2461-2464.
18. Dresios J, Aschrafi A, Owens GC, Vanderklish PW, Edelman GM, Mauro VP. (2005). Cold stress-induced protein Rbm3 binds 60S ribosomal subunits, alters microRNA levels, and enhances global protein synthesis. Proc Natl Acad Sci USA 102: 1865-1870
19. Dubois RN, Abramson SB, Crofford L, Gupta RA, Simon LS, Van De Putte LB et al. (1998). Cyclooxygenase in biology and disease. FASEB J 12: 1063-1073.
20. Eberhart CE, Coffey RJ, Radhika A, Giardiello FM, Ferrenbach S, DuBois RN. (1994). Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 107: 1183-1188.
21. Erkinheimo TL, Lassus H, Sivula A, Sengupta S, Furneaux H, Hla T et al. (2003). Cytoplasmic HuR expression correlates with poor outcome and with cyclooxygenase 2 expression in serous ovarian carcinoma. Cancer Res 63: 7591-7594.
22. Erkinheimo TL, Sivula A, Lassus H, Heinonen M, Furneaux H, Haglund C et al. (2005). Cytoplasmic HuR expression correlates with epithelial cancer cell but not with stromal cell cyclooxygenase-2 expression in mucinous ovarian carcinoma. Gynecol Oncol 99: 14-19.
23. Fan XC, Steitz JA. (1998a). HNS, a nuclear-cytoplasmic shuttling sequence in HuR. Proc Natl Acad Sci USA 95: 15293-15298.
24. Fan XC, Steitz JA. (1998b). Overexpression of HuR, a nuclear-cytoplasmic shuttling protein, increases the in vivo stability of ARE-containing mRNAs. EMBO J 17: 3448-3460.
25. Hacker S, Krebber H. (2004). Differential export requirements for shuttling serine/arginine-type mRNA-binding proteins. J Biol Chem 279: 5049-5052.
26. Heinonen M, Bono P, Narko K, Chang SH, Lundin J, Joensuu H et al. (2005). Cytoplasmic HuR expression is a prognostic factor in invasive ductal breast carcinoma. Cancer Res 65: 2157-2161.
27. Krysan K, Reckamp KL, Dalwadi H, Sharma S, Rozengurt E, Dohadwala M et al. (2005). Prostaglandin E2 activates mitogen-activated protein kinase/Erk pathway signaling and cell proliferation in non-small cell lung cancer cells in an epidermal growth factor receptor-independent manner. Cancer Res 65: 6275-6281.
28. Landegren U. (1984). Measurement of cell numbers by means of the endogenous enzyme hexosaminidase. Applications to detection of lymphokines and cell surface antigens. J Immunol Methods 67: 379-388.
29. Landen Jr CN, Chavez-Reyes A, Bucana C, Schmandt R, Deavers MT, Lopez-Berestein G et al. (2005). Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery. Cancer Res 65: 6910-6918.
30. Lopez de Silanes I, Fan J, Yang X, Zonderman AB, Potapova O, Pizer ES et al. (2003). Role of the RNA-binding protein HuR in colon carcinogenesis. Oncogene 22: 7146-7154.
31. Maller JL. (1991). Mitotic control. Curr Opin Cell Biol 3: 269-275.
32. Millar JB, Russell P. (1992). The cdc25 M-phase inducer: an unconventional protein phosphatase. Cell 68: 407-410.
33. Mukhopadhyay D, Houchen CW, Kennedy S, Dieckgraefe BK, Anant S. (2003a). Coupled mRNA stabilization and translational silencing of cyclooxygenase-2 by a novel RNA binding protein, CUGBP2. Mol Cell 11: 113-126.
34. Mukhopadhyay D, Jung J, Murmu N, Houchen CW, Dieckgraefe BK, Anant S. (2003b). CUGBP2 plays a critical role in apoptosis of breast cancer cells in response to genotoxic injury. Ann N Y Acad Sci 1010: 504-509.
35. Munkarah AR, Morris R, Baumann P, Deppe G, Malone J, Diamond MP et al. (2002). Effects of prostaglandin E(2) on proliferation and apoptosis of epithelial ovarian cancer cells. J Soc Gynecol Investig 9: 168-173.
36. Myer VE, Fan XC, Steitz JA. (1997). Identification of HuR as a protein implicated in AUUUA-mediated mRNA decay. EMBO J 16: 2130-2139.
37. Nabors LB, Gillespie GY, Harkins L, King PH. (2001). HuR, a RNA stability factor, is expressed in malignant brain tumors and binds to adenine- and uridine-rich elements within the 3′ untranslated regions of cytokine and angiogenic factor mRNAs. Cancer Res 61: 2154-2161.
38. Ning S, Knox SJ. (1999). G2/M-phase arrest and death by apoptosis of HL60 cells irradiated with exponentially decreasing low-dose-rate gamma radiation. Radiat Res 151: 659-669.
39. Ohi R, Gould KL. (1999). Regulating the onset of mitosis. Curr Opin Cell Biol 11: 267-273.
40. Peng SS, Chen CY, Xu N, Shyu AB. (1998). RNA stabilization by the AU-rich element binding protein, HuR, an ELAV protein. EMBO J 17: 3461-3470.
41. Pinol-Roma S. (1997). HnRNP proteins and the nuclear export of mRNA. Semin Cell Dev Biol 8: 57-63.
42. Ristimaki A, Narko K, Hla T. (1996). Down-regulation of cytokine-induced cyclo-oxygenase-2 transcript isoforms by dexamethasone: evidence for post-transcriptional regulation. Biochem J 318(Pt 1): 325-331.
43. Shao J, Lee SB, Guo H, Evers BM, Sheng H. (2003). Prostaglandin E2 stimulates the growth of colon cancer cells via induction of amphiregulin. Cancer Res 63: 5218-5223.
44. Sheng H, Shao J, Morrow JD, Beauchamp RD, DuBois RN. (1998). Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells. Cancer Res 58: 362-366.
45. Sheng H, Shao J, Washington MK, DuBois RN. (2001). Prostaglandin E2 increases growth and motility of colorectal carcinoma cells. J Biol Chem 276: 18075-18081.
46. Shyu AB, Wilkinson MF. (2000). The double lives of shuttling mRNA binding proteins. Cell 102: 135-138.
47. Smart F, Aschrafi A, Atkins A, Owens GC, Pilotte J, Cunningham BA et al. (2007). Two isoforms of the cold-inducible mRNA-binding protein RBM3 localize to dendrites and promote translation. J Neurochem 101: 1367-1379.
48. Stark GR, Taylor WR. (2004). Analyzing the G2/M checkpoint. Methods Mol Biol 280: 51-82.
49. Sureban SM, Murmu N, Rodriguez P, May R, Maheshwari R, Dieckgraefe BK et al. (2007). Functional antagonism between RNA binding proteins HuR and CUGBP2 determines the fate of COX-2 mRNA translation. Gastroenterology 132: 1055-1065.
50. Sutherland LC, Rintala-Maki ND, White RD, Morin CD. (2005). RNA binding motif (RBM) proteins: a novel family of apoptosis modulators? J Cell Biochem 94: 5-24.
51. Taylor WR, Stark GR. (2001). Regulation of the G2/M transition by p53. Oncogene 20: 1803-1815.
52. Wahl AF, Donaldson KL, Fairchild C, Lee FY, Foster SA, Demers GW et al. (1996). Loss of normal p53 function confers sensitization to Taxol by increasing G2/M arrest and apoptosis. Nat Med 2: 72-79.
53. Walworth NC. (2001). DNA damage: Chk1 and Cdc25, more than meets the eye. Curr Opin Genet Dev 11: 78-82.
54. Wang D, Mann JR, DuBois RN. (2005). The role of prostaglandins and other eicosanoids in the gastrointestinal tract. Gastroenterology 128: 1445-1461.
55. Wu G, Yi J, Di F, Zou S, Li X. (2005). Celecoxib inhibits proliferation and induces apoptosis via cyclooxygenase-2 pathway in human pancreatic carcinoma cells. J Huazhong Univ Sci Technolog Med Sci 25: 42-44.
56. Yamashita H, Osaki M, Honjo S, Yoshida H, Teshima R, Ito H. (2003). A selective cyclooxygenase-2 inhibitor, NS-398, inhibits cell growth by cell cycle arrest in a human malignant fibrous histiocytoma cell line. Anticancer Res 23: 4671-4676.